Bifidobacterium activated the STING pathway in dendritic cells, thereby enhancing the production of type I interferon for further stimulation of anti-tumor responses mediated by CD8+ T cells in combination with anti-CD47 therapy. This evidence concerns the gene STING1 and neoplasm.